Programmed Cell Death-Ligand 1 Expression Status in Urothelial Carcinoma According to Clinical and Pathological Factors: A Multi-Institutional Retrospective Study

Purpose: To investigate programmed cell death-ligand 1 (PD-L1) expression status and the clinical and pathological factors related to its expression in urothelial carcinoma (UC) patients.Materials and Methods: Data from 761 UC patients who underwent testing for PD-L1 expression using the VENTANA (SP...

Full description

Bibliographic Details
Published in:Frontiers in Oncology
Main Authors: Hyung Suk Kim, Won Sik Jang, Won Sik Ham, Seung Il Jung, Dong Hyun Lee, Ja Hyeon Ku, Hong Koo Ha, Ja Yoon Ku, Se Young Choi, In Ho Chang, Taesoo Choi, Wan Song, Seong Soo Jeon, Byong Chang Jeong, Sung Han Kim, Ho Kyung Seo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Subjects:
urothelial carcinoma
immune cell
programmed cell death-ligand 1
immunohistochemistry
immune checkpoint
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.568809/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.568809/full

Similar Items